Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.

    Song CH, Park SY, Eom KY, Kim JH, Kim SW, Kim JS, Kim IA.

    Breast Cancer Res. 2010;12(2):R20. Epub 2010 Mar 12.

    PMID:
    20226014
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.

    Capodanno A, Camerini A, Orlandini C, Baldini E, Resta ML, Bevilacqua G, Collecchi P.

    Hum Pathol. 2009 Oct;40(10):1408-17. Epub 2009 May 9.

    PMID:
    19428048
    [PubMed - indexed for MEDLINE]
    3.

    Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.

    Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, Kappler M, Lebigot I, Djelti F, Tourdès A, Gestraud P, Hupé P, Barillot E, Cruzalegui F, Tucker GC, Stern MH, Thiery JP, Hickman JA, Dubois T.

    Breast Cancer Res. 2008;10(6):R101. Epub 2008 Dec 3.

    PMID:
    19055754
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Activation of PI3K is associated with reduced survival in renal cell carcinoma.

    Merseburger AS, Hennenlotter J, Kuehs U, Simon P, Kruck S, Koch E, Stenzl A, Kuczyk MA.

    Urol Int. 2008;80(4):372-7. Epub 2008 Jun 27.

    PMID:
    18587247
    [PubMed - indexed for MEDLINE]
    5.

    Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.

    Im SA, Lee KE, Nam E, Kim DY, Lee JH, Han HS, Seoh JY, Park HY, Cho MS, Han WS, Lee SN.

    Tumori. 2005 Nov-Dec;91(6):513-21.

    PMID:
    16457151
    [PubMed - indexed for MEDLINE]
    6.

    Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.

    Tokunaga E, Oki E, Kimura Y, Yamanaka T, Egashira A, Nishida K, Koga T, Morita M, Kakeji Y, Maehara Y.

    Breast Cancer Res Treat. 2007 Mar;101(3):249-57. Epub 2006 Sep 28.

    PMID:
    17006756
    [PubMed - indexed for MEDLINE]
    7.

    The Akt pathway in human breast cancer: a tissue-array-based analysis.

    Bose S, Chandran S, Mirocha JM, Bose N.

    Mod Pathol. 2006 Feb;19(2):238-45.

    PMID:
    16341149
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

    Panigrahi AR, Pinder SE, Chan SY, Paish EC, Robertson JF, Ellis IO.

    J Pathol. 2004 Sep;204(1):93-100.

    PMID:
    15307142
    [PubMed - indexed for MEDLINE]
    9.

    Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?

    Colakoglu T, Yildirim S, Kayaselcuk F, Nursal TZ, Ezer A, Noyan T, Karakayali H, Haberal M.

    Am J Surg. 2008 Jun;195(6):719-25. Epub 2008 Apr 28.

    PMID:
    18440486
    [PubMed - indexed for MEDLINE]
    10.

    Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

    McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

    Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

    PMID:
    16854453
    [PubMed - indexed for MEDLINE]
    11.

    PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.

    Pérez-Tenorio G, Alkhori L, Olsson B, Waltersson MA, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O.

    Clin Cancer Res. 2007 Jun 15;13(12):3577-84.

    PMID:
    17575221
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

    Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR, Aleskandarany M, Paish EC, Douglas Macmillan R, Nicholson RI, Ellis IO, Gee JM.

    Breast Cancer Res Treat. 2010 Jan;119(2):283-93. Epub 2009 Feb 24.

    PMID:
    19238537
    [PubMed - indexed for MEDLINE]
    13.

    Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.

    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.

    Endocr Relat Cancer. 2005 Dec;12(4):983-98.

    PMID:
    16322337
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.

    Carvalho S, Milanezi F, Costa JL, Amendoeira I, Schmitt F.

    Virchows Arch. 2010 Mar;456(3):235-43. Epub 2010 Feb 4.

    PMID:
    20130907
    [PubMed - indexed for MEDLINE]
    15.

    PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.

    López-Knowles E, O'Toole SA, McNeil CM, Millar EK, Qiu MR, Crea P, Daly RJ, Musgrove EA, Sutherland RL.

    Int J Cancer. 2010 Mar 1;126(5):1121-31.

    PMID:
    19685490
    [PubMed - indexed for MEDLINE]
    16.

    Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.

    McBride SM, Perez DA, Polley MY, Vandenberg SR, Smith JS, Zheng S, Lamborn KR, Wiencke JK, Chang SM, Prados MD, Berger MS, Stokoe D, Haas-Kogan DA.

    J Neurooncol. 2010 Mar;97(1):33-40. Epub 2009 Aug 25.

    PMID:
    19705067
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.

    Shoman N, Klassen S, McFadden A, Bickis MG, Torlakovic E, Chibbar R.

    Mod Pathol. 2005 Feb;18(2):250-9.

    PMID:
    15475931
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.

    Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.

    Cancer Res. 2005 Dec 1;65(23):11018-25.

    PMID:
    16322251
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.

    Janssen EA, Søiland H, Skaland I, Gudlaugson E, Kjellevold KH, Nysted A, Søreide JA, Baak JP.

    Cell Oncol. 2007;29(1):25-35.

    PMID:
    17429139
    [PubMed - indexed for MEDLINE]
    20.

    [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].

    Liu C, Zhou S, Ke CS, Li NP, Wu RL.

    Ai Zheng. 2007 Sep;26(9):929-36. Chinese.

    PMID:
    17927847
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk